Neutral
Ligand (LGND) Completes $15M Investment in Orchestra BioMed
Ligand Pharmaceuticals Inc. (LGND) has completed a $15 million payment to Orchestra BioMed, marking a scheduled installment of their royalty financing...
OBIO
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (0)
Latest OBIO News
Neutral
Research OBIO on:
Ad Space